Replies to post #130927 on Biotech Values

[ghmm]

These patients are typically taken off of dvt prophylaxis upon discharge for medical patients or about 6 weeks post op from joint surgery. But, in reality, many of them are medically complex, frail, sedentary patients for whom the objective risk of VTE is not much lower as a result of leaving the hospital.

In the NEJM write-up its mentioned that. Any chance this leads to an increase treatment duration with Enoxaparin in this patient population? Or that unlikely without studies which you point out are difficult to do.

[DewDiligence]

I agree that the Eliquis news today does not change the picture for enoxaparin use significantly.

Neither does today’s news change the picture much for BMY and PFE, IMO.